4-MINUTE READ
In brief
An evolution of engagement
1
Pharma companies need to do more to better understand and meet the expectations of HCPs due to COVID-19.
2
When pharma companies do more, they are recognized and rewarded by HCPs with more time and attention.
3
HCPs most value connections that blend the best of virtual and in-person, focused on the needs of their patients.
75%
of HCPs have seen a decrease in patient numbers over the past year.
61%
have more capacity available than before COVID-19.
Visit our Subscription and Preference Center